Skip to main content
Log in

Treatment of SPG5 with cholesterol-lowering drugs

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tsaousidou MK, Ouahchi K, Warner TT, Yang Y, Simpson MA, Laing NG, Wilkinson PA, Madrid RE, Patel H, Hentati F, Patton MA, Hentati A, Lamont PJ, Siddique T, Crosby AH (2008) Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet 82:510–515

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Schüle R, Siddique T, Deng HX, Yang Y, Donkervoort S, Hansson M, Madrid RE, Siddique N, Schöls L, Björkhem I (2010) Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis. J Lipid Res 51:819–823

    Article  PubMed Central  PubMed  Google Scholar 

  3. Heverin M, Meaney S, Lütjohann D, Diczfalusy U, Wahren J, Björkhem I (2005) Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res 46:1047–1052

    Article  CAS  PubMed  Google Scholar 

  4. Mignarri A, Malandrini A, Del Puppo M, Magni A, Monti L, Ginanneschi F, Tessa A, Santorelli FM, Federico A, Dotti MT (2014) Hereditary spastic paraplegia type 5: a potentially treatable disorder of cholesterol metabolism. J Neurol 261:617–619

    Article  PubMed  Google Scholar 

  5. Dai D, Mills PB, Footitt E, Gissen P, McClean P, Stahlschmidt J, Coupry I, Lavie J, Mochel F, Goizet C, Mizuochi T, Kimura A, Nittono H, Schwarz K, Crick PJ, Wang Y, Griffiths WJ, Clayton PT (2014) Liver disease in infancy caused by oxysterol 7 α-hydroxylase deficiency: successful treatment with chenodeoxycholic acid. J Inherit Metab Dis 37:851–861

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Authors would like to thank Gianluca Marangi for excellent nursing and Claudio Salvadori for laboratory assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Teresa Dotti.

Ethics declarations

Conflicts of interest

We declare that we have no conflicts of interest.

Funding

We declare no funding.

Ethical standard

This study has been approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mignarri, A., Malandrini, A., Del Puppo, M. et al. Treatment of SPG5 with cholesterol-lowering drugs. J Neurol 262, 2783–2785 (2015). https://doi.org/10.1007/s00415-015-7971-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-015-7971-5

Keywords

Navigation